Collectively, the current study for the first to link the therapeutic effect of rTMS on ischemic stroke with microglial polarization and reveal the possible molecular mechanism was associated with let-7b-5p/HMGA2/NF-κB pathway. This evidence concerns the gene NFKB1 and ischemic stroke.